Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03631290 · ClinicalTrials.gov registry record
Deprescribing for Older Dialysis Patients
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 48
- Enrollment target
NCT03631290 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 48 participants.
The verdict
NCT03631290 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
Aim 1 of the study is to identify the elements of a deprescribing intervention that address contextual factors specific to dialysis. Aim 2 of the study, described in this record, is to determine the feasibility of a deprescribing intervention tailored for older dialysis patients. Older adults receiving dialysis are often prescribed multiple medications. Some of these medications are used to treat symptoms, but they also can increase the chance of significant health problems. The purpose of this study is to identify if it is feasible to reduce the use of medications that have been identified as causing an increased risk for health problems.
Interventions
- BEHAVIORAL Deprescribing Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2022-03-09 |
| Est. Completion | 2023-12-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03631290
The ClinicalTrials.gov registry entry for NCT03631290 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Deprescribing Intervention is the first listed.
NCT03631290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03631290 about?
NCT03631290 is a clinical study titled "Deprescribing for Older Dialysis Patients". Aim 1 of the study is to identify the elements of a deprescribing intervention that address contextual factors specific to dialysis. Aim 2 of the study, described in this record, is to determine the feasibility of a deprescribing intervention tailored for older dialysis patients. Older adults rece...
What is the current status of trial NCT03631290?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2022-03-09. Estimated completion is 2023-12-13.
What interventions are being tested in trial NCT03631290?
The interventions under investigation include: Deprescribing Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03631290?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.